Tacrolimus
FDA Approved
Contents
Description
Tacrolimus is an immunosuppressant drug used to prevent organ rejection after transplantation. It is also used off-label for certain autoimmune conditions.
Indications & Therapeutic Use
Organ transplant rejection prophylaxis, Atopic dermatitis, Steroid-resistant nephrotic syndrome
Global Availability (5 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Tacrolimus — GNH India
269 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
ACH-TACROLIMUS
0.5 MGcapsule (immediate release)CANADA
Adoport
5mgcapsuleUK
Adport
EU
Advagraf
EU
Ascezo
EU
Carelimus
EU
Cellmune
EU
Conferoport
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Tacrolimus
| Generic Name | Tacrolimus |
| Brands | 1 brand available |
| Active Ingredient | Tacrolimus |
| Drug Class | Organ transplant rejection prophylaxis |
| Manufacturer | Astellas Pharma |
| Dosage Forms | Capsule, Tablet, IV solution |
| Medical Code | L04AD02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT04104801 |
| Countries | 5 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations6 Validated Nodes